Lista de obras -

2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque

artículo científico publicado en 2014

Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure ⬇️

artículo científico publicado en 2019

Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals

artículo científico publicado en 2017

Arterial inflammation in patients with HIV.

artículo científico publicado en 2012

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus

artículo científico publicado en 2017

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial

article

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

artículo científico publicado en 2021

Authors' Reply to Comments on "Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study"

artículo científico publicado en 2019

Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study

scientific article published on 01 September 2018

Cardiovascular disease risk among women living with HIV in North America and Europe

artículo científico publicado en 2017

Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort

scientific article published on 18 July 2019

Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum

artículo científico publicado en 2020

Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial

artículo científico publicado en 2020

Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

artículo científico publicado en 2020

Differential Plasma Protein Regulation and Statin Effects in HIV-infected and Non-HIV-infected Patients Utilizing a Proteomics Approach Protein Regulation and Statin Effects in HIV

scientific article published on 20 April 2020

Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection

artículo científico publicado en 2016

Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV

artículo científico publicado en 2020

Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation

artículo científico publicado en 2010

Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.

artículo científico publicado en 2017

Elevated ischemic stroke risk among women living with HIV infection

artículo científico publicado en 2017

Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIV.

artículo científico publicado en 2017

Estrogen Sulfotransferase Is Expressed in Subcutaneous Adipose Tissue of Obese Humans in Association with TNF-α and SOCS3 ⬇️

artículo científico publicado el 4 de mayo de 2011

Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial

artículo científico publicado en 2017

HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy

artículo científico publicado en 2017

HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque

artículo científico publicado en 2014

HIV Infection and Heart Failure Outcomes in Women.

artículo científico publicado en 2017

HIV-Specific Immune Dysregulation and Atherosclerosis ⬇️

artículo científico publicado el 1 de septiembre de 2012

Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations

scientific article published on 01 October 2019

Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center

artículo científico publicado en 2019

Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus

artículo científico publicado en 2020

Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals

Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIV

article

Increased Fdg Uptake in Association with Reduced Extremity Fat in HIV Patients ⬇️

artículo científico publicado el 5 de octubre de 2012

Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda

article

Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients

artículo científico publicado en 2014

Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men

artículo científico publicado en 2013

Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences

artículo científico publicado en 2019

Measures of Adipose Tissue Redistribution and Atherosclerotic Coronary Plaque in HIV

scientific article published on 21 February 2020

Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

artículo científico publicado en 2020

Novel mediators of statin effects on plaque in HIV: a proteomics approach

artículo científico publicado en 2018

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

artículo científico publicado en 2020

Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV.

artículo científico publicado en 2017

Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV.

artículo científico publicado en 2017

Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure

article

Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers

artículo científico publicado en 2019

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

artículo científico publicado en 2019

Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV

artículo científico publicado en 2015

Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal‐weight subjects ⬇️

artículo científico publicado el 1 de septiembre de 2012

Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV

article

Reply

Risk of coronary heart disease in patients with HIV infection

artículo científico publicado en 2014

Sex Differences in Circulating Biomarkers of Cardiovascular Disease

artículo científico publicado en 2019

Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation

artículo científico publicado en 2017

Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals with HIV on Antiretroviral Therapy

artículo científico publicado en 2018

Sleep Apnea and Heart Failure with a Reduced Ejection Fraction Among Persons Living with HIV.

artículo científico publicado en 2018

Striving to characterize endocrine-metabolic and immune health risks among transgender women with HIV

scientific article published on 01 April 2019

Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals

artículo científico publicado en 2016

Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination

artículo científico publicado en 2020

TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome ⬇️

artículo científico publicado el 3 de noviembre de 2010

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

article by Nazir Savji et al published August 2018 in JACC: Heart Failure

The Risk for Sudden Cardiac Death Among Patients Living With Heart Failure and Human Immunodeficiency Virus

scientific article published on 07 August 2019

Vascular Dysfunction and Monocyte Activation among Women with HIV

artículo científico publicado en 2020

Lista de obras de

2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque

Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure ⬇️

Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals

Arterial inflammation in patients with HIV.

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

Authors' Reply to Comments on "Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study"

Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study

Cardiovascular disease risk among women living with HIV in North America and Europe

Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort

Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum

Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial

Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Differential Plasma Protein Regulation and Statin Effects in HIV-infected and Non-HIV-infected Patients Utilizing a Proteomics Approach Protein Regulation and Statin Effects in HIV

Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection

Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV

Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation

Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.

Elevated ischemic stroke risk among women living with HIV infection

Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIV.

Estrogen Sulfotransferase Is Expressed in Subcutaneous Adipose Tissue of Obese Humans in Association with TNF-α and SOCS3 ⬇️

Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial

HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy

HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque

HIV Infection and Heart Failure Outcomes in Women.

HIV-Specific Immune Dysregulation and Atherosclerosis ⬇️

Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations

Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center

Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus

Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals

Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIV

Increased Fdg Uptake in Association with Reduced Extremity Fat in HIV Patients ⬇️

Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda

Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients

Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men

Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences

Measures of Adipose Tissue Redistribution and Atherosclerotic Coronary Plaque in HIV

Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

Novel mediators of statin effects on plaque in HIV: a proteomics approach

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV.

Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV.

Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure

Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV

Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal‐weight subjects ⬇️

Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV

Reply

Risk of coronary heart disease in patients with HIV infection

Sex Differences in Circulating Biomarkers of Cardiovascular Disease

Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation

Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals with HIV on Antiretroviral Therapy

Sleep Apnea and Heart Failure with a Reduced Ejection Fraction Among Persons Living with HIV.

Striving to characterize endocrine-metabolic and immune health risks among transgender women with HIV

Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals

Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination

TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome ⬇️

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

The Risk for Sudden Cardiac Death Among Patients Living With Heart Failure and Human Immunodeficiency Virus

Vascular Dysfunction and Monocyte Activation among Women with HIV